Business Context and Reporting Period
This Form 8-K filing by Harvard Bioscience, Inc. reports on the results of the 2015 Annual Meeting of Stockholders held on May 28, 2015. The filing details the voting outcomes for four specific proposals regarding corporate governance, equity plans, and executive compensation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on stockholder voting results and does not contain financial performance data.
Material Changes and Voting Results
Stockholders voted on four proposals with the following outcomes:
- Proposal 1 (Election of Directors): Three Class III Directors were elected for three-year terms.
- Jeffrey A. Duchemin: Elected (18,630,614 votes for; 6,198,119 withheld).
- Earl R. Lewis: Elected (11,859,474 votes for; 12,969,259 withheld).
- George Uveges: Elected (18,010,860 votes for; 6,817,873 withheld).
- Proposal 2 (Stock Plan Amendment): Approved an amendment to increase authorized shares available for issuance under the 2000 Stock Option and Incentive Plan by 2,500,000 shares.
- Votes For: 16,604,072
- Votes Against: 7,918,765
- Votes Abstained: 305,896
- Proposal 3 (Auditor Ratification): Ratified the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2015.
- Votes For: 30,079,258
- Votes Against: 304,714
- Votes Abstained: 14,937
- Proposal 4 (Executive Compensation): Approved, via non-binding advisory vote, the compensation of named executive officers.
- Votes For: 13,907,200
- Votes Against: 10,681,172
- Votes Abstained: 240,361
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to reporting the historical voting results of the Annual Meeting.
Important Facts for Investors to Verify
- Verify the impact of the 2,500,000 share increase to the stock option plan on potential future dilution.
- Note the significant number of votes withheld for Director Earl R. Lewis (12.9 million withheld vs. 11.8 million for), indicating potential shareholder dissatisfaction despite his election.
- Confirm the split in the advisory vote on executive compensation, where votes against (10.6 million) were substantial compared to votes for (13.9 million).
- Review the full proxy statement for detailed biographies of the newly elected directors and the specific terms of the stock plan amendment.